Latest 10-Q quarterly reports

Metagenomi Therapeutics, Inc. filed its quarterly report for the period ending June 30, 2026, detailing ongoing research and development efforts, financial performance, and risk factors.

Oxford Square Capital Corp. filed its Form 10-Q for the quarter ended June 30, 2026, detailing a decrease in net asset value per share and mixed financial performance.

Allegiant Travel Company's Q2 2026 10-Q filing reveals substantial revenue increases and operational improvements, largely attributed to the recent acquisition of Sun Country Airlines, while navigating higher fuel costs and integration efforts.

Ceva Inc. reported a 13% year-over-year revenue increase to $29.0 million in Q2 2026, driven by strong licensing performance and growing royalty streams.

Entravision Communications Corporation reported a substantial increase in net revenue for the second quarter of 2026, driven by a significant expansion in its Advertising Technology & Services (ATS) segment.

Gaia, Inc. reported a 5.29% decrease in revenue for Q2 2026 compared to Q2 2025, alongside an increase in operating expenses and a net loss attributable to common shareholders of $3.0 million.

Vera Therapeutics announced its second-quarter 2026 financial results, highlighting increased operating expenses and continued net losses, while also noting the accelerated approval of its lead product, TRUTAKNA.

Olema Pharmaceuticals reported a significant increase in operating expenses, leading to a wider net loss for the period, despite continued progress in its clinical development programs.

ProKidney Corp. reported a net loss of $28.4 million for Q2 2026, with significant increases in R&D expenses and substantial doubt raised about its ability to continue as a going concern.

Quantum Computing Inc. (QUBT) reported substantial revenue growth in its Q2 2026 Form 10-Q, driven by recent acquisitions, but also disclosed significant operating losses and material weaknesses in internal controls.

Life360, Inc. announced a 38% year-over-year increase in total revenue for the second quarter of 2026, driven by significant growth in subscription and advertising segments.

UnitedHealth Group's Q2 2026 results show a significant increase in earnings and operating income, driven by strong performance across its segments, despite slight declines in membership.

Ardent Health reported a decrease in total revenue for the three months ended June 30, 2026, driven by lower net patient service revenue per adjusted admission, while operating expenses increased significantly.

Crescent Capital BDC, Inc. filed its Form 10-Q for the quarter ended June 30, 2026, detailing a decrease in investment income and an increase in non-accrual investments.

Axsome Therapeutics announced robust revenue increases for its key products AUVELITY, SUNOSI, and SYMBRAVO, but also reported substantial operating losses.

Orchestra BioMed Holdings, Inc. reported its Q2 2026 financial results, showing a significant increase in net loss driven by higher R&D expenses and substantial interest costs, though a gain from a strategic investment provided some offset.

Franklin Financial Services Corporation announced a significant increase in net income for the second quarter of 2026, driven by growth in net interest income and non-interest income, alongside robust asset and deposit expansion.

ProCap Acquisition Corp reports net income driven by interest earned on its trust account, while managing operational costs and awaiting a business combination.

Chiron Real Estate Inc. reported strong Q2 2026 results, driven by strategic acquisitions of seniors housing communities and a significant gain from the sale of investment properties.

Rocket Pharmaceuticals reports a significant financial boost from a $180 million Priority Review Voucher sale and FDA accelerated approval for its KRESLADI gene therapy, while advancing its cardiovascular pipeline.

TEN Holdings, Inc. filed its Form 10-Q for the quarter ended June 30, 2026, revealing a 34.5% year-over-year revenue decrease and a widening net loss, while also disclosing ongoing government investigations.

Phunware, Inc. announced its second quarter 2026 financial results, showing a significant increase in net revenue driven by software subscriptions and services, but also a widening net loss and increased operating expenses.

American Battery Materials Inc. reported a net loss of $5.19 million for the first six months of 2026, with significant accumulated deficits and a working capital shortfall casting doubt on its going concern status.

Fractyl Health's Q2 2026 report highlights clinical advancements in metabolic disease treatments but raises substantial doubt about its ability to continue as a going concern.

AAON, Inc. announced a substantial 101.2% increase in net sales for the second quarter of 2026, primarily fueled by the high-demand BASX data center cooling solutions.

FTAI Infrastructure Inc. reported a net loss of $139.4 million for the three months ended June 30, 2026, despite a significant increase in total revenues.

Telos Corporation announced a 32.7% increase in revenue for the second quarter of 2026, driven by its Security Solutions segment, and achieved a net income of $0.7 million, a significant improvement from the prior year's loss.

Seadrill Limited announced a significant increase in operating profit and revenues for the second quarter of 2026, driven by higher dayrates and improved utilization, alongside a successful $700 million senior notes issuance.

SCYNEXIS, Inc. reports a net loss for the quarter but highlights a substantial capital raise and progress in its SCY-770 and SCY-247 development programs.

Motorcar Parts of America, Inc. reported a net loss of $13.4 million for the three months ended June 30, 2026, a significant downturn from a profit in the prior year, alongside a 10.8% decrease in net sales.